Instreamatic, Pandora announce trial of AI-based interactive voice ads
Category: #tech  By Mateen Dalal  Date: 2019-04-03
  • share
  • Twitter
  • Facebook
  • LinkedIn

Instreamatic, Pandora announce trial of AI-based interactive voice ads

Platform of Instreamatic allows advertisers to use interactive voice ads that let consumers verbally and naturally respond to offers

Reports confirm that Instreamatic has announced an agreement with the largest streaming service in the U.S., Pandora, for testing AI-powered interactive voice advertising.

Instreamatic, for the record, is a platform for voice-enabled ads that allows advertisers and media companies to manage, monetize and measure audio content by using its interactive voice AI technology.

Supposedly, visual digital advertising is published across mobile, video interfaces, and web, in which audio itself cannot be clicked. The platform of Instreamatic has solved this key challenge by allowing advertisers to use interactive voice ads that let consumers verbally and naturally respond to offers.

Citing reliable sources, one of the capabilities of Instreamatic is voice AI that utilizes natural language understanding (NLU) to enable customer conversations to move beyond simply yes or no interactions. Apparently, the AI functionality of Instreamatic is designed to interpret, study and understand user intent and continuously improve this understanding through profound learning mechanisms.

Through this way, the platform continues to learn and raise its predictive power and vocabulary. In addition, the platform also looks to persistently improve the performance of ad campaigns as well as consumer’s ad experiences, sources commented.

Simultaneously, the technology of Instreamatic enables every interaction to be cautiously measured with a view to provide significant ad metrics that inform campaign policy and help manage ad spend decisions. Instreamatic’s platform also drives preliminary performance results which prove that allowing customers have dialogs with ads leads to richer engagement.

Sources further informed that through voice-driven engagement, the listeners of Pandora would get a natural utility, especially those consuming mobile audio content at the time of hand-free activities like working out, cooking. Here, advertisers will have the opportunity to engage their audiences at times when they were previously not able to respond. In coming years, Pandora is looking forward to offering test opportunities to advertisers.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AstraZenecas Farxiga gets fast track status to treat heart failure
AstraZenecas Farxiga gets fast track status to treat heart failure
By Mateen Dalal

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Upstream Works, Aceyus to pioneer customer experience solutions
Upstream Works, Aceyus to pioneer customer experience solutions
By Mateen Dalal

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW
By Mateen Dalal

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...